Detalles de la búsqueda
1.
Apalutamide for Metastatic, Castration-Sensitive Prostate Cancer.
N Engl J Med
; 381(1): 13-24, 2019 07 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31150574
2.
Health-related quality of life after apalutamide treatment in patients with metastatic castration-sensitive prostate cancer (TITAN): a randomised, placebo-controlled, phase 3 study.
Lancet Oncol
; 20(11): 1518-1530, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31578173
3.
Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 study.
Lancet Oncol
; 16(2): 152-60, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25601341
4.
Abiraterone acetate for patients with metastatic castration-resistant prostate cancer progressing after chemotherapy: final analysis of a multicentre, open-label, early-access protocol trial.
Lancet Oncol
; 15(11): 1263-8, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-25242048
5.
Outcomes of Patients with Advanced Urothelial Carcinoma after Anti-programmed Death-(ligand) 1 Therapy by Fibroblast Growth Factor Receptor Gene Alteration Status: An Observational Study.
Eur Urol Open Sci
; 47: 48-57, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36601039
6.
Phase II clinical trial of bexarotene gel 1% in psoriasis.
J Drugs Dermatol
; 6(5): 501-6, 2007 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-17679184
7.
A phase 3, double-blind, randomized placebo-controlled efficacy and safety study of abiraterone acetate in chemotherapy-naïve patients with mCRPC in China, Malaysia, Thailand and Russia.
Asian J Urol
; 4(2): 75-85, 2017 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-29264210
8.
Radiographic progression-free survival as a response biomarker in metastatic castration-resistant prostate cancer: COU-AA-302 results.
J Clin Oncol
; 33(12): 1356-63, 2015 Apr 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-25624432
Resultados
1 -
8
de 8
1
Próxima >
>>